The company has beaten earnings estimates in all four of the last four quarters by an average of roughly 21% and is growing revenue at 26% year-over-year, but a forward price-to-earnings multiple of 37.3 times and a risk/reward ratio of roughly 0.9-to-1 mean the story is compelling in quality and execution but not yet compelling in price.
Thesis pillars
- Perfect Earnings Beat Streak↓Deteriorating
- Strong Revenue Growth Profile→Stable
- Rich Valuation Limits Near Term Return↑Improving
- +1 more pillar — see the Why tab for full reasoning
BWX Technologies, Inc. (BWXT) Stock Analysis
Recovery setup · Catalyst-Driven edge
Industrials · Aerospace & Defense
Sell if holding. Momentum 3.7/10 is below the 5.0 floor at $134.44 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3); Sector modifier (Industrials): -0.7.
BWX Technologies manufactures precision naval nuclear components, reactor fuel, and medical radioisotopes across two segments: Government Operations (DOE/NNSA Naval Nuclear Propulsion Program) and Commercial Operations (nuclear power utilities, principally Canada, and life... Read more
Sell if holding. Momentum 3.7/10 is below the 5.0 floor at $134.44 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3); Sector modifier (Industrials): -0.7. Chart setup: Death cross but MACD improving, RSI 44. Score 5.4/10, high confidence.
Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 18d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: speculative.
About BWX Technologies, Inc.
About BWX Technologies, Inc.
BWX Technologies entered 2026 with $7.261 billion in total backlog — $5.541 billion (76%) in Government Operations and $1.720 billion (24%) in Commercial Operations — and expects to recognize approximately 40% of that revenue by year-end 2026. U.S. Government contracts represented approximately 68% of 2025 total consolidated revenues. The company delivers precision naval nuclear components, reactor fuel, medical radioisotopes, and nuclear services from manufacturing facilities across the U.S. and Canada.
Government Operations revenue flows primarily from long-term fixed-price incentive fee contracts with the DOE/NNSA Naval Nuclear Propulsion Program, under which BWX Technologies has supplied nuclear components since the 1950s. Supplementary revenue comes from joint-venture management and operation of DOE nuclear facilities and environmental remediation sites, with partners including Huntington Ingalls Industries, Amentum Environment & Energy, Bechtel National, and Fluor Federal Services. Commercial Operations revenue depends on the cyclical timing of nuclear power plant maintenance outages and life-extension refurbishments, principally in Canada, where the majority of Ontario plants are expected to require refurbishment. The January 2025 acquisition of Aerojet Ordnance Tennessee from L3Harris expanded advanced-materials capabilities, and the May 2025 acquisition of Kinectrics added nuclear lifecycle services and medical isotope production. In commercial nuclear components, primary competitors include Framatome, Doosan Heavy Industries, Westinghouse Electric Corporation, and Cameco Corporation.
Show full overview
BWXT Technologies' revenues are materially dependent on Congressional appropriations and DOE funding levels. The 10-K discloses that budget reductions or a government shutdown could produce program delays, production halts, employee furloughs, and non-payment. Counterbalancing this risk, the U.S. Navy's March 2024 30-year shipbuilding plan — with all three procurement profiles indicating sustained or increased nuclear submarine and aircraft carrier procurement — provides long-horizon visibility that supports the company's expectation that naval nuclear component orders will remain a significant portion of backlog for the foreseeable future.
See also: Industrials · Aerospace & Defense
From BWX Technologies, Inc.'s most recent 10-K filing, extracted June 9, 2026.
Recent developments
updated 2026-10-15Recent Developments — BWX Technologies, Inc.
Latest news
- NEWS BWX Technologies Q1 Earnings Loom: What Should You Do Now? - TradingView — TradingView neutral
- NEWS Concurrent Investment Advisors LLC Grows Stake in BWX Technologies, Inc. $BWXT - MarketBeat — MarketBeat neutral
- NEWS BWX Technologies (BWXT) Plans New Uranium Enrichment Facility - Yahoo Finance — Yahoo Finance positive
- NEWS BWX Technologies (BWXT) Is Down 7.3% After Removal From Russell Defensive Indexes Post mPower Deal - simplywall.st — simplywall.st negative
- NEWS BWX Technologies (NYSE:BWXT) Shares Drop 3%; Market Consensus Points to 23% H2 EPS Rise - TechStock² — TechStock² positive
Generated 2026-10-15T11:42:22Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 3.7/10 is below the 5.0 floor at $134.44 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3); Sector modifier (Industrials): -0.7. Chart setup: Death cross but MACD improving, RSI 44. Prior stop was $127.90. Score 5.4/10, high confidence.
Take-profit target: $188.50 (+40.2% upside). Prior stop was $127.90. Stop-loss: $127.90.
V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3); Sector modifier (Industrials): -0.7; Leverage penalty (D/E 1.5): -1.0.
BWX Technologies, Inc. trades at a P/E of 35.9 (forward 25.7). TrendMatrix value score: 5.2/10. Verdict: Sell.
23 analysts cover BWXT with a consensus score of 4.1/5. Average price target: $209.
What does BWX Technologies, Inc. do?BWX Technologies manufactures precision naval nuclear components, reactor fuel, and medical radioisotopes across two...
BWX Technologies manufactures precision naval nuclear components, reactor fuel, and medical radioisotopes across two segments: Government Operations (DOE/NNSA Naval Nuclear Propulsion Program) and Commercial Operations (nuclear power utilities, principally Canada, and life sciences). U.S. Government contracts comprised approximately 68% of 2025 consolidated revenues, with $7.261 billion in backlog at year-end 2025.